UNSPSC 51101640: Broxyquinoline

This classification denotes an anti-infective agent with the molecular formula C9H5Br2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UK4C618C8T, chemically known as 5,7-dibromooxine but generally known as broxyquinoline, which bears US NIH Compound Identifier 2453. European Medicines Agency schedules Broxyquinoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05940MIG.

UNSPSC 51101640 Broxyquinoline, a Commodity code, does not align with the recent state and local opportunities tagged under it. The solicitations instead cover naloxone and drug deactivation systems, therapeutic pharmacy initiatives, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and over-the-counter products — none of which involve broxyquinoline, a halogenated quinoline compound with specialized industrial or antimicrobial applications. The mismatch suggests either misclassification in the source records or that the code is not currently active in state and local procurement. No recent opportunities directly soliciting broxyquinoline were identified in the available records.

The four opportunities posted between January and June 2026 span health and human services agencies and municipal fire departments across Florida, Texas, and Minnesota, but they do not reflect demand for the code's nominal commodity. If broxyquinoline procurement exists at the state and local level, it is not surfacing in current market activity under this code classification and warrants verification against actual buyer requisitions and historical awards before pursuing a market entry strategy.